Breaking News

ABC Labs, Missouri U Establish Internship Program

By Kristin Brooks | December 11, 2013

Science majors to gain work experience in private industry

ABC Laboratories and The University of Missouri Department of Biochemistry have entered a joint initiative to offer science majors work experience in private industry. The Biochemistry Department will offer the course Biochemistry 4001—Industry Internship, where ABC scientists will participate in lectures and the company will offer paid internships under the program.
ABC president and chief executive officer, John Bucksath, said, “So many students pursuing an education in life sciences think of academia or medicine as their only career paths. In fact, there is a tremendous demand for scientific brainpower in private industry.” ABC is a CRO that provides product development services to heavily regulated industries such as pharmaceuticals and agrochemicals.
Chris Lee, Ph.D., assistant professor with MU’s Department of Biochemistry, said, “This internship opportunity presents a chance for our students to explore a career in the biotech industry while working to finish their degree. Hopefully this experience provides the technical training along with the theoretical background in science to make our students competitive hires at ABC or related biotech companies.”
  • Patheon Furthers Expansion Strategy

    Kristin Brooks, Contract Pharma||January 9, 2017
    Patrick Glaser of Patheon discusses expanded manufacturing capacity, capabilities, and future plans

  • API Sourcing Trends

    Kristin Brooks, Contract Pharma||April 11, 2016
    Drug product complexities, quality and regulatory hurdles drive market shift

  • Setting a Precedent for Biosimilars in the U.S.

    Setting a Precedent for Biosimilars in the U.S.

    Kristin Brooks, Contract Pharma||May 19, 2015
    Niall Dinwoodie of Charles River discusses several key industry issues on biosimilars and addresses some of the development and regulatory hurdles that remain

  • Limiting APIs in Manufacturing Effluent

    Limiting APIs in Manufacturing Effluent

    Joan Tell, Robert Drinane, Bruce Naumann, Jessica Vestel, and Gregory Gagliano, Merck & Co., Inc.||June 2, 2016
    An approach for setting limits on pharmaceuticals discharged in manufacturing effluent

  • Biopharma CMO Market Trends

    Biopharma CMO Market Trends

    Tim Wright, Editor||June 2, 2016
    Continued strong growth in biopharma industry is being driven by biosimilars

  • Continuous Pharmaceutical Processes and Their Demands

    Continuous Pharmaceutical Processes and Their Demands

    Girish Malhotra, EPCOT International||April 5, 2016
    A look at the unique characteristics of continuous processes in pharmaceutical manufacturing.